Alnylam Pharmaceuticals, Inc. (ALNY) Investigation: Bronstein, Gewirtz ...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 7, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alnylam Pharmaceuticals, Inc. ("Alnylam" or "the Company") (NASDAQ:ALNY). Investors who purchased Alnylam securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/ALNY. Alnylam Investigation Details On July 30, 2026, Alnylam announced second-quarter 2026 financial results. Among other things, the Company reported it has "lowered our TTR product sales guidance for full-year 2026 to reflect learnings from the initial phase of our launch in the evolving ATTR-CM market, in particular the ..
Read releases like this the second they cross the wire.
1400+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 72-hour free trial, no card required.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.
PPN Source →